GoldenGolden
Advanced Search
ChromaCode

ChromaCode

ChromaCode is a Carlsbad, California-based company developing molecular diagnostics and bioinformatics systems.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

May 19, 2020
ChromaCode raises a $10,000,000 series C round from Adjuvant Capital.
December 17, 2019
ChromaCode raises a $28,000,000 series C round from Northpond Ventures.
April 2017
ChromaCode raises a $12,000,000 series B round from Domain Associates, New Enterprise Associates and Okapi Venture Capital.

Funding rounds

People

Further reading

Documentaries, videos and podcasts

Companies

News

Title
Author
Date
Publisher
Description
Conor Hale
March 16, 2021
FierceBiotech
Nine teams have been selected as the winners of XPrize's $6 million COVID-19 testing competition, with the goal of providing affordable and accurate diagnostics to help ensure the safety of everyday activities.
ChromaCode
December 22, 2020
www.prnewswire.com:443
/PRNewswire/ -- ChromaCode, Inc. today announced that the company has been named a finalist in the $6 million XPRIZE Rapid Covid Testing competition, a...
Jonathan Shieber
May 19, 2020
TechCrunch
Boasting a technology that can dramatically increase the capacity of existing polymerase chain reaction (PCR) testing used to identify people infected with COVID-19 and other illnesses, ChromaCode has attracted new funding from Bill Gates-backed Adjuvant Capital. "We want a good solution for a resource-limited environment," says ChromaCode founder and executive chairman Alex Wilkinson, a serial entrepreneur [...]
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.